Call Our HELPLINE: 1-800-4PD-INFO (473-4636)

National Parkinson Foundation Campaign Promotes the Power of Exercise During Parkinson’s Disease Awareness Month

The National Parkinson Foundation (NPF) launched the #Move4PD campaign in recognition of National Parkinson’s Disease Awareness Month today. The campaign’s goal is to highlight the importance of exercise for those with Parkinson’s disease (PD) and its positive effects on the brain.

“People living with Parkinson’s can have a positive impact on the course of their own disease,” said Paul Blom, NPF’s Interim CEO. “NPF has long championed the role of exercise in slowing the symptoms of Parkinson’s.”

Research from NPF’s Parkinson’s Outcomes Project has proven that 2.5 hours of exercise per week has a significant difference on the quality of life for those with PD. Regular physical activity is linked to improved mobility and less cognitive decline.

NPF is asking the community to unite and support its mission to help every person diagnosed with Parkinson’s live their best possible life during National Parkinson’s Disease Awareness Month. Here’s how the community can help spread awareness:

NPF will host a photo competition via social media asking followers to post “workout selfies” while showing off their awareness month sweatbands, for a chance to win a NPF prize. Participants are encouraged to submit and share their My PD Story to spread awareness about the disease, letting others know that they are not alone in the fight against PD.

The #Move4PD campaign will kick-off nationally on March 21, 2016, celebrating National Parkinson’s Disease Awareness Month throughout April. Each week, followers will be asked to post pictures of themselves working out while proudly wearing their official NPF sweatband, which can be ordered during the last week of March.

About Parkinson’s Disease (PD)
Affecting an estimated one million Americans and four to six million worldwide, Parkinson’s disease is the second most common neurodegenerative disease after Alzheimer’s and is the 14th leading cause of death in the United States. There is no cure for PD and 60,000 new cases are diagnosed each year in the United States alone.

Monday, March 21, 2016
Parkinson's Foundation Study Finds Gender Disparities in Caregiving, with Women at a Disadvantage
Monday, December 4, 2017

Largest Clinical Study Tracking Parkinson’s Patients Over Time Shows Women with Parkinson’s Have Fewer Caregiving Resources than Men with Parkinson’s

Parkinson’s Foundation Invests $60,000 to Develop Innovative Models of Patient Engagement
Wednesday, November 29, 2017

Six Awards Foster Patient-Driven Parkinson’s Research

Jesse Jackson Diagnosed with Parkinson's Disease
Friday, November 17, 2017

Rev. Jesse Jackson’s announcement today that he has been living with Parkinson’s Disease since 2015 further proves that receiving a diagnosis of Parkinson's is not a death sentence. There are many ways that people living with Parkinson's can control the symptoms of the disease with exercise and physical therapy to help maintain mobility and balance.

Update on Tozadenant Trial for Parkinson’s
Thursday, November 16, 2017

On 11/20/17, Acorda Therapeutics, Inc. announced that it is discontinuing the tozadenant clinical trial.  They concluded that they could not be confident that weekly white blood cell count screening would sufficiently ensure patient safety.

Parkinson’s Foundation Adds Marcia Mondavi Borger to Board of Directors
Tuesday, November 14, 2017

NEW YORK & MIAMI — The Parkinson’s Foundation today announced the election of Marcia Mondavi Borger to its Board of Directors.

Parkinson’s Foundation and Melvin Yahr International Parkinson’s Disease Foundation Announce Merger
Thursday, October 26, 2017

Parkinson’s Foundation Establishes ‘Dr. Melvin Yahr Research Award’ to Fund Neurology Fellows, Promote Leadership Diversity in Parkinson’s Research

Parkinson’s Foundation Welcomes Two New Board Members
Tuesday, October 24, 2017

Peter Goldman and Joshua Raskin Join Board of Directors

NEW YORK & MIAMI — The Parkinson’s Foundation today announced the election of Chicago entrepreneur Peter Goldman and New York financial analyst Joshua Raskin to its Board of Directors.

Parkinson's Foundation Unveils New Brand and Website
Thursday, October 19, 2017

NEW YORK and MIAMI /PRNewswire-USNewswire/ — The Parkinson's Foundation today announced the launch of its new brand and website following the recent merger of two legacy organizations – National Parkinson Foundation and Parkinson's Disease Foundation – as part of its mission to

FDA Approves Extended-Release Amantadine (GOCOVRI™) for Treatment of Dyskinesia
Friday, August 25, 2017

Statement from the Parkinson's Foundation Medical Director, Michael Okun, MD

Parkinson’s Foundation Announces $1.2 Million Investment to Advance Careers, Support Innovation of Early Career Parkinson’s Scientists
Tuesday, August 8, 2017

NEW YORK & MIAMI The Parkinson's Foundation is pleased to announce a $1.2 million investment in 27 career development and fellowship grants to support the work of promising early career scientists in the field of Parkinson's.

Pages

mail icon

Subscribe to get the latest news on treatments, research and other updates.